Ashland Inc. (NYSE:ASH) Positions For Stabilization As Dividend Continues Payouts

Ashland enters a near-term phase of operational stabilization supported by solid liquidity metrics and a maintained quarterly dividend. Technical signals point to constrained downside with potential mean-reversion pressure toward valuation anchors.

Recent News

On August 8, 2025 the board declared a quarterly cash dividend of $0.415 per share, payable September 15, 2025 to shareholders of record September 1, 2025; shares outstanding reported as 45,709,431 as of July 31, 2025.

Technical Analysis

Directional indicators show low trend strength: ADX at 15.36 indicates no strong trend, which aligns with a technical regime that favors range-bound action and reduces the probability of sustained breakout moves.

DI+ sits at 21.71 and DI- at 24.22; DI+ shows a decreasing pattern while DI- exhibits a dip-and-reversal (DI- increasing). Those directional moves skew short-term bias toward sellers, adding pressure against the valuation support zone and increasing the chance that price tests lower targets before any sustainable recovery.

MACD at -1.0 with a declining trend and a signal line at -0.4 indicates negative momentum. MACD remains below its signal line, reinforcing bearish momentum and weighing on near-term price strength relative to the current valuation level.

MRO registers -29.28 and continues decreasing; the negative value signals price sits below the model target, implying mean-reversion potential that could push the price higher over time if fundamentals stabilize. The current MRO magnitude suggests meaningful upside potential if momentum reverses.

RSI at 47.22 and trending down shows momentum below neutral and trending toward oversold territory; this reduces the likelihood of immediate bullish continuation and increases the probability of consolidation near recent lows while valuation metrics digest.

Price sits below all relevant averages: close $47.89 versus the 12-day EMA $50.70, 26-day EMA $51.91, 20-day average $51.46, 50-day average $52.49 and 200-day average $56.40. That alignment of price beneath moving averages signals technical weakness and indicates the near-term path of least resistance remains lower-to-flat until momentum indicators improve.

Bollinger placement finds price below the 1x lower band ($49.14) but above the 2x lower band ($46.83), signaling action near the lower trading band and suggesting compression that often precedes either a corrective bounce or a trend continuation; the lack of strong ADX points toward a bounce as the higher-probability scenario unless selling pressure expands.

Ichimoku components cluster near current price (Tenkan $51.42, Kijun $52.41, Senkou A $52.16, Senkou B $51.25) and form a narrow cloud above price, so the Ichimoku structure currently represents resistance that must clear before a sustained bullish re-acceleration consistent with the WMDST valuation level.

Volume recently averages modestly above the 10- and 50-day averages (today’s volume ~695K vs 10-day avg 656K and 50-day avg 546K), indicating heavier participation on recent moves; watch whether elevated volume accompanies directional follow-through, since that will define whether the technical regime shifts away from the present range.

 


Fundamental Analysis

Profitability and earnings: net income for the period shows a loss of $742,000,000 and EBIT at -$689,000,000, producing an EBIT margin of -148.81%. QoQ change in EBIT margin shows a -14.20% move, while YoY EBIT margin improved by 13.46% from the prior year. EPS came in at $1.04 versus an estimate of $1.21, an EPS surprise of -14.05% (difference -$0.17).

Cash flow and liquidity: operating cash flow stands at $106,000,000 with free cash flow $86,000,000 and cash and short-term investments $207,000,000. The cash ratio equals 0.49 and the current ratio equals 2.68, which compares favorably to the industry peer mean current ratio of 1.964 — indicating stronger near-term liquidity relative to typical peers. Cash conversion cycle remains long at 143.63 days, noticeably above the industry peer mean of 93.13 days, which extends working-capital requirements and weighs on cash generation timing.

Leverage and capital structure: total debt $1,485,000,000 and net debt $1,175,000,000 produce debt-to-assets of 32.14% and debt-to-equity of 0.79. Debt levels increased QoQ on the reported metrics; interest expense remains modest at $15,000,000, but interest coverage reflects compression given negative operating earnings, producing an interest coverage ratio of -45.93.

Margins and returns: gross margin at 28.51% contrasts with negative operating and EBIT margins, reflecting cost and portfolio mix impacts. Return on assets equals -15.06% and return on equity equals -39.28%, both marking material declines YoY and QoQ. Revenue totaled $463,000,000 with YoY revenue growth at -38.05% and quarter-over-quarter revenue dynamics showing contraction, consistent with portfolio optimization actions noted in company communications.

Valuation context: price-to-sales at 5.22 and P/B at 1.28 sit within the company’s historical and peer-relative spectrum, while trailing PE remains negative. Free cash flow yield at 3.56% stands above the industry peer mean free cash flow yield of 0.96%, providing a valuation cushion relative to cash generation. The current valuation as determined by WMDST: under-valued.

Company commentary around portfolio optimization and cost actions aligns with the reported metrics and the WMDST valuation, with the operational cashflows and dividend commitment supporting the case for a valuation gap versus the company’s recent profitability headlines.

MOST-RECENT QUARTERLY REPORT
REPORT PERIOD ENDING: 2025-06-30
REPORT DATE: 2025-07-29
NEXT REPORT DATE: 2025-10-29
CASH FLOW  Begin Period Cash Flow 168.0 M
 Operating Cash Flow 106.0 M
 Capital Expenditures -20.00 M
 Change In Working Capital 68.0 M
 Dividends Paid -19.00 M
 Cash Flow Delta 39.0 M
 End Period Cash Flow 207.0 M
 
INCOME STATEMENT REVENUE
 Total Revenue 463.0 M
 Forward Revenue -10.21 M
COSTS
 Cost Of Revenue 331.0 M
 Depreciation 61.0 M
 Depreciation and Amortization 76.0 M
 Research and Development 13.0 M
 Total Operating Expenses 465.0 M
PROFITABILITY
 Gross Profit 132.0 M
 EBITDA -613.00 M
 EBIT -689.00 M
 Operating Income -2.00 M
 Interest Income 1.0 M
 Interest Expense 15.0 M
 Net Interest Income -17.00 M
 Income Before Tax -704.00 M
 Tax Provision 15.0 M
 Tax Rate 21.0 %
 Net Income -742.00 M
 Net Income From Continuing Operations -741.00 M
EARNINGS
 EPS Estimate 1.21
 EPS Actual 1.04
 EPS Difference -0.17
 EPS Surprise -14.05 %
 Forward EPS 1.43
 
BALANCE SHEET ASSETS
 Total Assets 4.6 B
 Intangible Assets 1.3 B
 Net Tangible Assets 606.0 M
 Total Current Assets 1.1 B
 Cash and Short-Term Investments 207.0 M
 Cash 207.0 M
 Net Receivables 201.0 M
 Inventory 567.0 M
 Long-Term Investments 542.0 M
LIABILITIES
 Accounts Payable 185.0 M
 Short-Term Debt
 Total Current Liabilities 420.0 M
 Net Debt 1.2 B
 Total Debt 1.5 B
 Total Liabilities 2.7 B
EQUITY
 Total Equity 1.9 B
 Retained Earnings 2.3 B
VALUATION & PER-SHARE METRICS EQUITY & PER-SHARE METRICS
 Book Value Per-Share 41.33
 Shares Outstanding 45.706 M
 Revenue Per-Share 10.13
VALUATION
 Market Capitalization 2.4 B
 Enterprise Value 3.7 B
 Enterprise Multiple -6.024
Enterprise Multiple QoQ -117.308 %
Enterprise Multiple YoY -100.712 %
Enterprise Multiple IPRWA high: 85.583
median: 84.899
mean: 60.383
ASH: -6.024
low: -118.916
 EV/R 7.976
CAPITAL STRUCTURE
 Asset To Equity 2.446
 Asset To Liability 1.691
 Debt To Capital 0.44
 Debt To Assets 0.321
Debt To Assets QoQ 13.091 %
Debt To Assets YoY 4296.17 %
Debt To Assets IPRWA high: 0.733
median: 0.378
mean: 0.34
ASH: 0.321
low: 0.021
 Debt To Equity 0.786
Debt To Equity QoQ 35.285 %
Debt To Equity YoY 5451.766 %
Debt To Equity IPRWA high: 2.523
median: 0.962
mean: 0.829
ASH: 0.786
low: 0.024
PRICE-BASED VALUATION
 Price To Book (P/B) 1.278
Price To Book QoQ 23.504 %
Price To Book YoY -17.281 %
Price To Book IPRWA high: 14.757
median: 6.71
mean: 5.297
ASH: 1.278
low: 0.307
 Price To Earnings (P/E) -3.22
Price To Earnings QoQ -105.499 %
Price To Earnings YoY -105.109 %
Price To Earnings IPRWA high: 139.289
median: 139.289
mean: 104.624
low: -0.783
ASH: -3.22
 PE/G Ratio 0.002
 Price To Sales (P/S) 5.216
Price To Sales QoQ -5.682 %
Price To Sales YoY -38.122 %
Price To Sales IPRWA high: 20.44
median: 19.039
mean: 13.022
ASH: 5.216
low: 0.914
FORWARD MULTIPLES
Forward P/E 36.474
Forward PE/G -0.021
Forward P/S -236.432
EFFICIENCY OPERATIONAL
 Operating Leverage 411.918
ASSET & SALES
 Asset Turnover Ratio 0.094
Asset Turnover Ratio QoQ 2.643 %
Asset Turnover Ratio YoY 1.01 %
Asset Turnover Ratio IPRWA high: 0.334
median: 0.175
mean: 0.161
ASH: 0.094
low: 0.003
 Receivables Turnover 2.169
Receivables Turnover Ratio QoQ -11.942 %
Receivables Turnover Ratio YoY -3.528 %
Receivables Turnover Ratio IPRWA high: 2.422
ASH: 2.169
mean: 1.473
median: 1.361
low: 0.117
 Inventory Turnover 0.597
Inventory Turnover Ratio QoQ -3.808 %
Inventory Turnover Ratio YoY -9.794 %
Inventory Turnover Ratio IPRWA high: 2.465
median: 1.426
mean: 1.184
ASH: 0.597
low: 0.034
 Days Sales Outstanding (DSO) 42.077
CASH CYCLE
 Cash Conversion Cycle Days (CCC) 143.634
Cash Conversion Cycle Days QoQ -1.511 %
Cash Conversion Cycle Days YoY 24.681 %
Cash Conversion Cycle Days IPRWA high: 488.171
ASH: 143.634
mean: 93.129
median: 55.264
low: 5.01
CAPITAL DEPLOYMENT
 Cash Conversion Ratio 0.658
 CapEx To Revenue -0.043
 CapEx To Depreciation -0.328
 
CAPITAL, LIQUIDITY & COVERAGE CAPITAL STRUCTURE
 Total Capital 3.3 B
 Net Invested Capital 3.3 B
 Invested Capital 3.3 B
 Net Tangible Assets 606.0 M
 Net Working Capital 704.0 M
LIQUIDITY
 Cash Ratio 0.493
 Current Ratio 2.676
Current Ratio QoQ 15.263 %
Current Ratio YoY -10.343 %
Current Ratio IPRWA high: 6.372
ASH: 2.676
mean: 1.964
median: 1.53
low: 1.35
 Quick Ratio 1.326
Quick Ratio QoQ 15.202 %
Quick Ratio YoY -27.86 %
Quick Ratio IPRWA high: 3.851
mean: 1.332
ASH: 1.326
median: 1.122
low: 0.803
COVERAGE & LEVERAGE
 Debt To EBITDA -2.423
 Cost Of Debt 0.797 %
 Interest Coverage Ratio -45.933
Interest Coverage Ratio QoQ -1375.926 %
Interest Coverage Ratio YoY 1048.333 %
Interest Coverage Ratio IPRWA high: 24.749
median: 9.66
mean: 8.252
low: -21.281
ASH: -45.933
 Operating Cash Flow Ratio -1.586
TIMING / LIQUIDITY
 Days Payables Outstanding (DPO) 50.847
DIVIDENDS
 Dividend Coverage Ratio -39.053
 Dividend Payout Ratio -0.026
 Dividend Rate 0.42
 Dividend Yield 0.008
PERFORMANCE GROWTH
 Asset Growth Rate -11.695 %
 Revenue Growth -3.34 %
Revenue Growth QoQ -118.279 %
Revenue Growth YoY -38.045 %
Revenue Growth IPRWA high: 47.859 %
median: 8.936 %
mean: 8.399 %
ASH: -3.34 %
low: -4.472 %
 Earnings Growth -1737.374 %
Earnings Growth QoQ -785.163 %
Earnings Growth YoY -10129.291 %
Earnings Growth IPRWA high: 346.154 %
mean: 26.372 %
median: 26.0 %
low: -380.0 %
ASH: -1737.374 %
MARGINS
 Gross Margin 28.51 %
Gross Margin QoQ -7.1 %
Gross Margin YoY -16.615 %
Gross Margin IPRWA high: 62.406 %
median: 42.61 %
mean: 37.831 %
ASH: 28.51 %
low: -24.576 %
 EBIT Margin -148.812 %
EBIT Margin QoQ -1420.075 %
EBIT Margin YoY 1345.619 %
EBIT Margin IPRWA high: 46.541 %
median: 18.287 %
mean: 14.958 %
low: -33.607 %
ASH: -148.812 %
 Return On Sales (ROS) -0.432 %
Return On Sales QoQ -103.832 %
Return On Sales YoY -95.803 %
Return On Sales IPRWA high: 23.528 %
median: 18.253 %
mean: 14.229 %
ASH: -0.432 %
low: -33.437 %
CASH FLOW
 Free Cash Flow (FCF) 86.0 M
 Free Cash Flow Yield 3.561 %
Free Cash Flow Yield QoQ -571.656 %
Free Cash Flow Yield YoY 87.717 %
Free Cash Flow Yield IPRWA high: 5.667 %
ASH: 3.561 %
mean: 0.964 %
median: 0.633 %
low: -1.464 %
 Free Cash Growth -530.0 %
Free Cash Growth QoQ 676.511 %
Free Cash Growth YoY -146.375 %
Free Cash Growth IPRWA high: 333.766 %
median: 266.0 %
mean: 21.738 %
ASH: -530.0 %
low: -926.923 %
 Free Cash To Net Income -0.116
 Cash Flow Margin -143.844 %
 Cash Flow To Earnings 0.898
VALUE & RETURNS
 Economic Value Added 0.03
 Return On Assets (ROA) -15.06 %
Return On Assets QoQ -2639.629 %
Return On Assets YoY -14721.359 %
Return On Assets IPRWA high: 11.068 %
median: 2.274 %
mean: 1.702 %
low: -7.448 %
ASH: -15.06 %
 Return On Capital Employed (ROCE) -16.401 %
 Return On Equity (ROE) -0.393
Return On Equity QoQ -3343.6 %
Return On Equity YoY -19545.545 %
Return On Equity IPRWA high: 0.233
median: 0.056
mean: 0.043
low: -0.097
ASH: -0.393
 DuPont ROE -33.363 %
 Return On Invested Capital (ROIC) -16.64 %
Return On Invested Capital QoQ -1680.247 %
Return On Invested Capital YoY -234.28 %
Return On Invested Capital IPRWA high: 4.864 %
median: 3.363 %
mean: 2.47 %
low: -6.68 %
ASH: -16.64 %

Six-Week Outlook

Price bias for the next six weeks favors range-bound to slightly bearish action until momentum indicators and short-term averages re-align above the 12–26 day EMA cluster. MRO’s negative reading implies mean-reversion potential that could fuel counter-trend rallies; however, MACD and RSI trends currently limit the scope of sustainable upside without a clear momentum reversal.

Key near-term market dynamics likely include consolidation around the current lower-Bollinger band and tests of the lower support zone near the 2x lower band, with any multi-day move above the 12-day EMA and a MACD inflection required to shift the outlook toward a constructive re-rating consistent with the under-valued WMDST assessment. Volume spikes accompanying directional moves will determine whether consolidation resolves into meaningful trend change or remains a transient bounce within the present range.

About Ashland Inc.

Ashland Global Holdings Inc. (NYSE:ASH) develops and supplies specialty chemicals and ingredients, serving a wide range of industries worldwide. Headquartered in Wilmington, Delaware, Ashland divides its operations into key segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. In the Life Sciences division, Ashland provides pharmaceutical solutions such as controlled release polymers and tablet coatings, as well as nutrition components like thickeners and emulsifiers. The Personal Care segment delivers biodegradable, nature-derived ingredients for oral care and household products, emphasizing sustainability and performance. The Specialty Additives segment plays a crucial role in offering rheology modifiers, surfactants, and advanced ceramics, which are essential for sectors including construction, energy, and electronics. Meanwhile, the Intermediates division focuses on the production of 1,4 butanediol and its derivatives, vital to various manufacturing processes. Ashland maintains a global footprint, reaching markets across North and Latin America, Europe, and the Asia Pacific region. Committed to innovation and sustainability, the company continually seeks to enhance its offerings, ensuring quality and customer satisfaction in the evolving landscape of specialty chemicals.



© 2025 WMDST — The World’s Most Dangerous Swing Trader. All rights reserved.